Patient characteristics associated with different types of prison TB: an epidemiological analysis of 921 TB cases diagnosed at an Ethiopian prison.
Epidemiology
Ethiopia
HIV
Prison TB
Tuberculosis
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
27 Oct 2021
27 Oct 2021
Historique:
received:
07
07
2021
accepted:
08
10
2021
entrez:
28
10
2021
pubmed:
29
10
2021
medline:
3
2
2022
Statut:
epublish
Résumé
Despite incarcerated population being at an increased risk of tuberculosis (TB) and serving as a potential source of TB transmission for the general population, prison TB remains understudied. Given its adverse impact on progress towards TB elimination, World Health Organization (WHO) has identified prison TB research as a top priority to guide TB treatment/control interventions. We retrospectively analyzed 921 notified TB cases that were diagnosed at Kality Federal Prison, Ethiopia during 2009-2017. To assess trends of microbiologically confirmed pulmonary TB (PTB), extra-pulmonary TB (EPTB), and TB-HIV co-infection, an ecological analysis of aggregated cases was used to report trends over time. Additionally, we used multivariable log binomial regression to identify patient characteristics associated with microbiologically confirmed PTB, EPTB, and TB-HIV co-infection. Microbiologically confirmed PTB proportion increased over time. Young age was identified as an important risk factor for EPTB (adjusted prevalence ratio [aPR] = 1.74, 95% CI 0.97, 3.13) while HIV coinfection was negatively associated with EPTB (aPR = 0.73, 95% CI 0.55, 0.97). While previous TB history was associated with a lower likelihood of EPTB (aPR = 0.42, 95% CI 0.25, 0.70), it was associated with an increased risk of TB-HIV coinfection (aPR = 1.37, 95% CI 1.10, 1.71). Clinically diagnosed PTB patients were more likely to have TB-HIV coinfection compared to microbiologically confirmed PTB patients (aPR = 1.32, 95% CI 1.02, 1.72). Increasing proportion of microbiologically confirmed PTB may suggest delayed access to treatment, severe disease and increased risk of intramural transmission. Associations with clinical/demographic factors varied for different types of TB and were not always consistent with what has been previously reported for the general population, necessitating the need to refocus prison TB control/treatment strategies based on context specific epidemiological factors.
Sections du résumé
BACKGROUND
BACKGROUND
Despite incarcerated population being at an increased risk of tuberculosis (TB) and serving as a potential source of TB transmission for the general population, prison TB remains understudied. Given its adverse impact on progress towards TB elimination, World Health Organization (WHO) has identified prison TB research as a top priority to guide TB treatment/control interventions.
METHODS
METHODS
We retrospectively analyzed 921 notified TB cases that were diagnosed at Kality Federal Prison, Ethiopia during 2009-2017. To assess trends of microbiologically confirmed pulmonary TB (PTB), extra-pulmonary TB (EPTB), and TB-HIV co-infection, an ecological analysis of aggregated cases was used to report trends over time. Additionally, we used multivariable log binomial regression to identify patient characteristics associated with microbiologically confirmed PTB, EPTB, and TB-HIV co-infection.
RESULTS
RESULTS
Microbiologically confirmed PTB proportion increased over time. Young age was identified as an important risk factor for EPTB (adjusted prevalence ratio [aPR] = 1.74, 95% CI 0.97, 3.13) while HIV coinfection was negatively associated with EPTB (aPR = 0.73, 95% CI 0.55, 0.97). While previous TB history was associated with a lower likelihood of EPTB (aPR = 0.42, 95% CI 0.25, 0.70), it was associated with an increased risk of TB-HIV coinfection (aPR = 1.37, 95% CI 1.10, 1.71). Clinically diagnosed PTB patients were more likely to have TB-HIV coinfection compared to microbiologically confirmed PTB patients (aPR = 1.32, 95% CI 1.02, 1.72).
CONCLUSIONS
CONCLUSIONS
Increasing proportion of microbiologically confirmed PTB may suggest delayed access to treatment, severe disease and increased risk of intramural transmission. Associations with clinical/demographic factors varied for different types of TB and were not always consistent with what has been previously reported for the general population, necessitating the need to refocus prison TB control/treatment strategies based on context specific epidemiological factors.
Identifiants
pubmed: 34706685
doi: 10.1186/s12890-021-01699-w
pii: 10.1186/s12890-021-01699-w
pmc: PMC8555052
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
334Informations de copyright
© 2021. The Author(s).
Références
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
PLoS One. 2019 Dec 12;14(12):e0226160
pubmed: 31830092
Int J Tuberc Lung Dis. 2001 Aug;5(8):696-702
pubmed: 11495258
Clin Infect Dis. 2010 May 15;50 Suppl 3:S67-70
pubmed: 20397958
Front Vet Sci. 2017 Nov 10;4:193
pubmed: 29177157
Lancet Glob Health. 2016 Nov;4(11):e806-e815
pubmed: 27720688
Eur Respir J. 2005 Aug;26(2):298-304
pubmed: 16055879
Epidemiol Infect. 2015 Apr;143(5):887-900
pubmed: 25376279
BMC Public Health. 2019 Dec 10;19(1):1658
pubmed: 31822286
Int J Infect Dis. 2015 Mar;32:111-7
pubmed: 25809766
PLoS Med. 2010 Dec 21;7(12):e1000381
pubmed: 21203587
J Int AIDS Soc. 2016 Nov 15;19(1):20960
pubmed: 27852420
Arch Public Health. 2017 Aug 21;75:37
pubmed: 28835818
BMC Pulm Med. 2019 May 10;19(1):91
pubmed: 31077178
PLoS One. 2014 Dec 10;9(12):e112213
pubmed: 25494360
Emerg Microbes Infect. 2018 Jun 6;7(1):102
pubmed: 29872046
Clin Infect Dis. 2004 Jan 15;38(2):199-205
pubmed: 14699451
PLoS One. 2013 Sep 09;8(9):e73717
pubmed: 24040038
Am J Trop Med Hyg. 2020 Jul;103(1):214-220
pubmed: 32431282
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):537-45
pubmed: 19223783
AIDS Res Hum Retroviruses. 2013 Jul;29(7):1045-55
pubmed: 23517547
J Immunoassay Immunochem. 2018;39(6):636-646
pubmed: 30296205
Occup Environ Med. 1998 Apr;55(4):272-7
pubmed: 9624282